Antibiotics, biomarkers, Intensive Care Unit, neutrophil CD64, prognosis, sepsis
Citation Information :
Chaturvedi S, Mishra P, Mishra R, Ghosh PS, Singh H, Baronia AK, Singh RK. Correlation of neutrophil CD64 with clinical profile and outcome of sepsis patients during intensive care unit stay. Indian J Crit Care Med 2018; 22 (8):569-574.
Introduction: Neutrophil CD64 (nCD64) has been found to identify sepsis from nonseptic patients. It is also reported to be a predictor of survival and severity of sepsis. The goal of this study was to correlate serial nCD64 with Intensive Care Unit (ICU) outcome and severity of sepsis.
Materials and Methods: A prospective observational study was conducted in 12-bedded critical care unit of a tertiary care center. Adult patients with sepsis were included in this study. Demographics, illness severity scores, clinical parameters, laboratory data, and 28-day outcome were recorded. Serial nCD64 analysis was done (on days 0, 4, and 8) in consecutive patients.
Results: Fifty-one consecutive patients were included in the study. Median Acute Physiology and Chronic Health Evaluation II was 16 (12–20) and mean Sequential Organ Failure Assessment was 9 (8–10). Compared to survivors, nonsurvivors had higher nCD64 on day 8 (P = 0.001). nCD64 was higher in the septic shock group compared to sepsis group on days 0 and 8 (P < 0.05). Survivors showed improving trend of nCD64 over time while nonsurvivors did not. This trend was similar in the presence or absence of septic shock. nCD64 count was a good predictor of the septic shock on day 0 (area under the curve [AUC] = 0.747, P = 0.010) and moderate predictor at day 8 (AUC = 0.679, P = 0.028).
Conclusion: Monitoring serial nCD64 during ICU stay may be helpful in determining the clinical course of septic patients.
Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: Secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006;10:R42.
Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 2013;41:580-637.
Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, et al. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis 2007;7:10.
Kirn TJ, Weinstein MP. Update on blood cultures: How to obtain, process, report, and interpret. Clin Microbiol Infect 2013;19:513-20.
Pazin GJ, Saul S, Thompson ME. Blood culture positivity: Suppression by outpatient antibiotic therapy in patients with bacterial endocarditis. Arch Intern Med 1982;142:263-8.
Reinhart K, Bauer M, Riedemann NC, Hartog CS. New approaches to sepsis: Molecular diagnostics and biomarkers. Clin Microbiol Rev 2012;25:609-34.
Davis BH, Bigelow NC. Comparison of neutrophil CD64 expression, manual myeloid immaturity counts, and automated hematology analyzer flags as indicators of infection or sepsis. Lab Hematol 2005;11:137-47.
Davis BH, Olsen SH, Ahmad E, Bigelow NC. Neutrophil CD64 is an improved indicator of infection or sepsis in emergency department patients. Arch Pathol Lab Med 2006;130:654-61.
Livaditi O, Kotanidou A, Psarra A, Dimopoulou I, Sotiropoulou C, Augustatou K, et al. Neutrophil CD64 expression and serum IL-8: Sensitive early markers of severity and outcome in sepsis. Cytokine 2006;36:283-90.
Cardelli P, Ferraironi M, Amodeo R, Tabacco F, De Blasi RA, Nicoletti M, et al. Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis. Int J Immunopathol Pharmacol 2008;21:43-9.
Danikas DD, Karakantza M, Theodorou GL, Sakellaropoulos GC, Gogos CA. Prognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expression. Clin Exp Immunol 2008;154:87-97.
Lobreglio GB, d'Aversa P, Leo L, Scolozzi S, Fiore G. Quantitative expression of CD64 on neutrophil granulocytes as early marker of sepsis or severe infection. Haematologica 2008;93:21.
Hsu KH, Chan MC, Wang JM, Lin LY, Wu CL. Comparison of fcγ receptor expression on neutrophils with procalcitonin for the diagnosis of sepsis in critically ill patients. Respirology 2011;16:152-60.
Gámez-Díaz LY, Enriquez LE, Matute JD, Velásquez S, Gómez ID, Toro F, et al. Diagnostic accuracy of HMGB-1, sTREM-1, and CD64 as markers of sepsis in patients recently admitted to the emergency department. Acad Emerg Med 2011;18:807-15.
Schiff DE, Rae J, Martin TR, Davis BH, Curnutte JT. Increased phagocyte fc gammaRI expression and improved fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood 1997;90:3187-94.
Davis BH. Improved diagnostic approaches to infection/sepsis detection. Expert Rev Mol Diagn 2005;5:193-207.
Song SH, Kim HK, Park MH, Cho HI. Neutrophil CD64 expression is associated with severity and prognosis of disseminated intravascular coagulation. Thromb Res 2008;121:499-507.
Hoffmann JJ. Neutrophil CD64: A diagnostic marker for infection and sepsis. Clin Chem Lab Med 2009;47:903-16.
Ng PC, Li G, Chui KM, Chu WC, Li K, Wong RP, et al. Neutrophil CD64 is a sensitive diagnostic marker for early-onset neonatal infection. Pediatr Res 2004;56:796-803.
Groselj-Grenc M, Ihan A, Pavcnik-Arnol M, Kopitar AN, Gmeiner-Stopar T, Derganc M, et al. Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children. Intensive Care Med 2009;35:1950-8.
Bhandari V, Wang C, Rinder C, Rinder H. Hematologic profile of sepsis in neonates: Neutrophil CD64 as a diagnostic marker. Pediatrics 2008;121:129-34.
Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 2000;118:146-55.
Fischer G, Schneider EM, Moldawer LL, Karcher C, Barth E, Suger-Wiedeck H, et al. CD64 surface expression on neutrophils is transiently upregulated in patients with septic shock. Intensive Care Med 2001;27:1848-52.
de Jong E, de Lange DW, Beishuizen A, van de Ven PM, Girbes AR, Huisman A, et al. Neutrophil CD64 expression as a longitudinal biomarker for severe disease and acute infection in critically ill patients. Int J Lab Hematol 2016;38:576-84.
Muller Kobold AC, Tulleken JE, Zijlstra JG, Sluiter W, Hermans J, Kallenberg CG, et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med 2000;26:883-92.
Cid J, Garcia-Pardo G, Aguinaco R, Sanchez R. Neutrophil CD 64: Diagnostic accuracy and prognostic value in patients presenting to the emergency department. Eur J Clin Microbiol Inf Dis 2011;30:845-52.
Hirsh M, Mahamid E, Bashenko Y, Hirsh I, Krausz MM. Overexpression of the high affinity Fc-g receptor (CD64) is associated with leucocyte dysfunction in sepsis. Shock 2001;16:102-8.
Icardi M, Erickson Y, Kilborn S, Stewart B, Grief B, Scharnweber G, et al. CD64 index provides simple and predictive testing for detection and monitoring of sepsis and bacterial infection in hospital patients. J Clin Microbiol 2009;47:3914-9.
Hoffmann JJ. Neutrophil CD64 as a sepsis biomarker. Biochem Med (Zagreb) 2011;21:282-90.
Tillinger W, Jilch R, Jilma B, Brunner H, Koeller U, Lichtenberger C, et al. Expression of the high-affinity IgG receptor fcRI (CD64) in patients with inflammatory bowel disease: A new biomarker for gastroenterologic diagnostics. Am J Gastroenterol 2009;104:102-9.
Bauer PR, Kashyap R, League SC, Park JG, Block DR, Baumann NA, et al. Diagnostic accuracy and clinical relevance of an inflammatory biomarker panel for sepsis in adult critically ill patients. Diagn Microbiol Infect Dis 2016;84:175-80.
Wang X, Li ZY, Zeng L, Zhang AQ, Pan W, Gu W, et al. Neutrophil CD64 expression as a diagnostic marker for sepsis in adult patients: A meta-analysis. Crit Care 2015;19:245.